Adalsteinn Gunnlaugsson
1 – 10 of 57
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Stereotactic body radiotherapy as metastasis-directed therapy in oligometastatic prostate cancer: a systematic review and meta-analysis of randomized controlled trials
2025) 12th Øresund Workshop on Radiotherapy(
- Contribution to conference › Abstract
-
Mark
Prostate-specific antigen bounce after prostate ultra-hypofractionation: associations with 5-year outcomes in the phase 3 trial HYPO-RT-PC
(
- Contribution to journal › Published meeting abstract
-
Mark
Effect of inaccurate b-values from imaging gradients on intravoxel incoherent motion
(
- Contribution to journal › Article
- 2024
-
Mark
Dose-volume relationships of planned versus estimated delivered radiation doses to pelvic organs at risk and side effects in patients treated with salvage radiotherapy for recurrent prostate cancer
(
- Contribution to journal › Article
-
Mark
Morbiditet från urinvägar och tarm enligt registerdata efter ultrahypofraktionerad strålbehandling för lokaliserad prostatacancer vid 10 år i HYPO-RT-PC-studien
2024) Onkologidagarna 2024(
- Contribution to conference › Poster
-
Mark
Register data on long-term morbidity after prostate cancer radiotherapy with ultra-hypofractionated (2.5 weeks) vs conventional (8 weeks) treatment schedules
2024) U21 Health Sciences Group 2024 Doctoral Student Forum(
- Contribution to conference › Poster
-
Mark
Accuracy of gross tumour volume delineation with [68Ga]-PSMA-PET compared to histopathology for high-risk prostate cancer
(
- Contribution to journal › Article
-
Mark
Behandling av icke spridd prostatacancer – individuellt val
(
- Contribution to journal › Article
-
Mark
Stereotactic body radiotherapy as metastasis-directed therapy in oligometastatic prostate cancer: a systematic review and meta-analysis of randomized controlled trials
(
- Contribution to journal › Article
-
Mark
Histopathology-validated gross tumor volume delineations of intraprostatic lesions using PSMA-positron emission tomography/multiparametric magnetic resonance imaging
(
- Contribution to journal › Article